QUAL vs XBI
iShares MSCI USA Quality Factor ETF vs SPDR S&P Biotech ETF
- • QUAL has the lower expense ratio at 0.15% vs 0.35% for XBI.
- • QUAL pays a higher dividend yield (0.91%).
Side-by-side metrics
| Metric | QUAL | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.15% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.91% | 0.34% |
AUM Assets under management — bigger funds are typically more liquid. | $50.11B | $8.30B |
YTD return | 5.98% | 12.92% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.93 | 1.09 |
P/E ratio | 27.72 | — |
Last price | $209.46 | $133.66 |
Inception | — | — |
Issuer | iShares | State Street |
QUAL top holdings
| NVDA | NVIDIA Corp | 6.50% |
| AAPL | Apple Inc | 6.27% |
| MSFT | Microsoft Corp | 5.04% |
| META | Meta Platforms Inc Class A | 3.49% |
| LRCX | Lam Research Corp | 3.22% |
| TJX | TJX Companies Inc | 3.19% |
| V | Visa Inc Class A | 3.08% |
| LLY | Eli Lilly and Co | 2.92% |
| KLAC | KLA Corp | 2.78% |
| GOOGL | Alphabet Inc Class A | 2.53% |
XBI top holdings
| APLS | Apellis Pharmaceuticals Inc | 1.87% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.65% |
| TVTX | Travere Therapeutics Inc Ordinary Shares | 1.62% |
| ARWR | Arrowhead Pharmaceuticals Inc | 1.44% |
| TWST | Twist Bioscience Corp | 1.42% |
| SMMT | Summit Therapeutics Inc Ordinary Shares | 1.40% |
| ALKS | Alkermes PLC | 1.38% |
| TGTX | TG Therapeutics Inc | 1.37% |
| MDGL | Madrigal Pharmaceuticals Inc | 1.36% |
| BEAM | Beam Therapeutics Inc | 1.32% |
About QUAL
QUAL (iShares MSCI USA Quality Factor ETF) is US large-caps screened for quality factors. Managed by iShares, the fund carries $50.1B in assets under management, an expense ratio of 0.15%, a dividend yield of 0.91%. Its largest holding is NVIDIA Corp (NVDA), which represents 6.5% of the portfolio. Real Estate is the fund's largest sector exposure at 1.8%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $8.3B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.34%. Its largest holding is Apellis Pharmaceuticals Inc (APLS), which represents 1.9% of the portfolio. Financial Services is the fund's largest sector exposure at 0.2%.